[1] 季明春.淋球菌外膜蛋白疫苗的研究进展.国外医学免疫学分册,2003,26:158-161. [2] Martin D, Cadieux N, Hamel J, et al. Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection. J Exp Med, 1997, 185:1173-1183. [3] Cadieux N, Plante M, Rioux CR, et al.Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein. Infect Immun, 1999, 67:4955-4959. [4] Moe GR, Zuno-Mitchell P, Hammond SN,et al. Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains. Infect Immun, 2002, 70:6021-6031. [5] Martin D, Brodeur BR, Hamel J, et al.Candidate Neisseria meningitidis NspA vaccine. J Biotechnol, 2000, 83:27-31. [6] Plante M, Cadieux N, Rioux CR, et al.Antigenic and molecular conservation of the gonococcal NspA protein. Infect Immun,1999, 67: 2855-2861. [7] 季明春,严华,陈红菊,等.耐药淋球菌差异DNA消减文库的构建及初步筛选.中华皮肤科杂志,2003,36:264-266. |